Platelets and renal failure in the SARS-CoV-2 syndrome

References

• Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis 2020 Jul;20(7):773. doi: https://doi.org/10.1016/S1473-3099(20)30195-X.
   Google Scholar
• Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 2020;395(10223):497–506. doi: https://doi.org/10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Xiong M, Liang X, Wei YD. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Br J Haematol 2020;189(6):1050–1052. doi: https://doi.org/10.1111/bjh.16725
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020;382(17):e38. doi: https://doi.org/10.1056/NEJMc2007575
   PubMed Web of Science ®Google Scholar
• Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt J-D, Sacco C, Alexia B. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020;191:9–14. doi: https://doi.org/10.1016/j.thromres.2020.04.024
   PubMed Web of Science ®Google Scholar
• Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. In: Maier H., Bickerton E., Britton P. (eds) Coronaviruses. Methods in Molecular Biology, vol 1282. New York, NY: Humana Press. doi: https://doi.org/10.1007/978-1-4939-2438-7_1
   Google Scholar
• Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 2005;309(5742):1864–1868. doi: https://doi.org/10.1126/science.1116480
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020;181(2):271–280.e8. doi: https://doi.org/10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426(6965):450–454. doi: https://doi.org/10.1038/nature02145
   PubMed Web of Science ®Google Scholar
• Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004;203(2):631–637. doi: https://doi.org/10.1002/path.1570
   PubMed Web of Science ®Google Scholar
• Tikellis C, Thomas M. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept 2012;2012:256294. doi: https://doi.org/10.1155/2012/256294.
   Google Scholar
• Senchenkova EY, Russell J, Esmon CT, Granger DN. Roles of coagulation and fibrinolysis in angiotensin II‐enhanced microvascular thrombosis. Microcirc 2014;21:401–407. doi: https://doi.org/10.1111/micc.12120
   PubMed Web of Science ®Google Scholar
• Fraga-Silva RA, Sorg BS, Wankhede M, deDeugd C, Jun JY, Baker MB, Li Y, Castellano RK, Katovich MJ, Raizada MK. ACE2 activation promotes antithrombotic activity. Mol Med 2010;16(5–6):210–215. doi: https://doi.org/10.2119/molmed.2009.00160
   PubMed Web of Science ®Google Scholar
• Liu N, Hong Y, Chen R-G, Zhu H-M. High rate of increased level of plasma Angiotensin II and its gender difference in COVID-19: an analysis of 55 hospitalized patients with COVID-19 in a single hospital, Wuhan, China. medRxiv 2020. doi: https://doi.org/10.1101/2020.04.27.20080432.
   Google Scholar
• Siragy HM, Carey RM. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am J Nephrol 2010;31(6):541–550. doi: https://doi.org/10.1159/000313363
   PubMed Web of Science ®Google Scholar
• Jagroop I, Mikhailidis D. Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan. J Hum Hypertens 2000;14(9):581–585. doi: https://doi.org/10.1038/sj.jhh.1001102
   PubMed Web of Science ®Google Scholar
• Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 2006;17(4):1143–1150. doi: https://doi.org/10.1681/ASN.2005091017
   PubMed Web of Science ®Google Scholar
• Martin-Loeches I, Papiol E, Rodríguez A, Diaz E, Zaragoza R, Granada RM, Socias L, Bonastre J, Valverdú M, Pozo JC. Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection. Critical Care 2011;15(1):R66. doi: https://doi.org/10.1186/cc10046
   PubMed Web of Science ®Google Scholar
• Bagshaw SM, George C, Bellomo R, Committee ADM. Early acute kidney injury and sepsis: a multicentre evaluation. Critical Care 2008;12:R47. doi: https://doi.org/10.1186/cc6863
   PubMed Web of Science ®Google Scholar
• Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995;273(2):117–123. doi: https://doi.org/10.1001/jama.1995.03520260039030
   PubMed Web of Science ®Google Scholar
• Di Micco P, Russo V, Carannante N, Imparato M, Rodolfi S, Cardillo G, Lodigiani C. Clotting Factors in COVID-19: epidemiological association and prognostic values in different clinical presentations in an Italian cohort. J Clin Med. 2020 May;9(5):1371. doi: https://doi.org/10.3390/jcm9051371.
   Google Scholar
• Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020. doi: https://doi.org/10.1007/s00134-020-06062-x
   Web of Science ®Google Scholar
• Wichmann D, Sperhake JP, Lutgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schroder AS, et al. Autopsy findings and venous thromboembolism in patients with COVID-19: A prospective cohort study. Ann Intern Med 2020. doi: https://doi.org/10.7326/M20-2003
   PubMedGoogle Scholar
• Simmons J, Pittet J-F. The coagulopathy of acute sepsis. Curr Opin Anaesthesiol 2015;28(2):227. doi: https://doi.org/10.1097/ACO.0000000000000163
   PubMed Web of Science ®Google Scholar
• LaRosa SP, Opal SM, Utterback B, Yan SCB, Helterbrand J, Simpson AJ, Chaowagul W, White NJ, Fisher CJ Jr. Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei. Int J Infect. Dis 2006;10:25–31. doi: https://doi.org/10.1016/j.ijid.2005.06.001
   PubMed Web of Science ®Google Scholar
• Venugopal A. Disseminated intravascular coagulation. Indian J Anaesth 2014;58(5):603. doi: https://doi.org/10.4103/0019-5049.144666
   PubMedGoogle Scholar
• Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002;13(5–6):301–306. doi: https://doi.org/10.1080/095371002220148332
   PubMed Web of Science ®Google Scholar
• Schmoeller D, Picarelli MM, Paz Munhoz T, Poli de Figueiredo CE, Staub HL. Mean platelet volume and immature platelet fraction in autoimmune disorders. Front Med 2017;4:146. doi: https://doi.org/10.3389/fmed.2017.00146
   PubMed Web of Science ®Google Scholar
• Nardin M, Verdoia M, Negro F, Rolla R, Tonon F, De Luca G. Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease. Eur J Clin Invest 2020;50(2):e13181. doi: https://doi.org/10.1111/eci.13181
   PubMed Web of Science ®Google Scholar
• Blair P, Flaumenhaft R. Platelet α-granules: basic biology and clinical correlates. Blood Rev 2009;23(4):177–189. doi: https://doi.org/10.1016/j.blre.2009.04.001
   PubMed Web of Science ®Google Scholar
• Chen Y, Yuan Y, Li W. Sorting machineries: how platelet-dense granules differ from α-granules. Biosci Rep. 2018 Oct 31; 38(5):BSR20180458. Published online 2018 Sep 7. doi: https://doi.org/10.1042/BSR20180458.
   Google Scholar
• West TE, von Saint André-von AA. Clinical presentation and management of severe Ebola virus disease. Ann Am Thorac Soc 2014;11(9):1341–1350. doi: https://doi.org/10.1513/AnnalsATS.201410-481PS
   PubMedGoogle Scholar
• McElroy AK, Erickson BR, Flietstra TD, Rollin PE, Nichol ST, Towner JS, Spiropoulou CF. Biomarker correlates of survival in pediatric patients with Ebola virus disease. Emerg Infect Dis 2014;20(10):1683. doi: https://doi.org/10.3201/eid2010.140430
   PubMed Web of Science ®Google Scholar
• Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, Jeanpierre E, Rauch A, Labreuche J, Susen S. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation 2020 Jul 14;142(2):184–186. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.047430.
   Google Scholar
• Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray M, Merouani K. High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients. J Thromb Haemost. 2020 Jul;18(7):1743–1746. doi: https://doi.org/10.1111/jth.14869.
   Google Scholar
• Rabelo LA, Alenina N, Bader M. ACE2–angiotensin-(1–7)–Mas axis and oxidative stress in cardiovascular disease. Hypertens Res 2011;34(2):154–160. doi: https://doi.org/10.1038/hr.2010.235
   PubMed Web of Science ®Google Scholar
• Samavati L, Uhal BD. ACE2, much more than just a receptor for SARS-COV-2. Front. Cell. Infect. Microbiol., 05 June 2020. doi:https://doi.org/10.3389/fcimb.2020.00317.
   Google Scholar
• Larsson P, Schwieler J, Wallen N. Platelet activation during angiotensin II infusion in healthy volunteers. Blood Coagulation Fibrinolysis 2000;11(1):61–69. doi: https://doi.org/10.1097/00001721-200011010-00007
   PubMed Web of Science ®Google Scholar
• Jiang F, Yang J, Zhang Y, Dong M, Wang S, Zhang Q, Liu FF, Zhang K, Zhang C. Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets. Nat Rev Cardiol 2014;11:413
   PubMed Web of Science ®Google Scholar
• Williams VR, Scholey JW. Angiotensin-converting enzyme 2 and renal disease. Curr Opin Nephrol Hypertens 2018;27(1):35–41. doi: https://doi.org/10.1097/MNH.0000000000000378
   PubMed Web of Science ®Google Scholar
• Menter T, Haslbauer J, Nienhold R, Savic S, Hopfer H, Deigendesch N, Frank S, Turek D, Willi N, Pargger H. Post‐mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction. The Histopathology of COVID‐19, August 2020;77(2):198–209.
   Google Scholar
• Ingelfinger JR. ACE2: a new target for prevention of diabetic nephropathy? Am Soc Nephrol 2006;17(11):2957–2959. doi: https://doi.org/10.1681/ASN.2006090986
   PubMed Web of Science ®Google Scholar
• Shah B, Sha D, Xie D, Mohler ER, Berger JS. The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey, 1999–2004. Diabetes Care 2012;35:1074–1078. doi: https://doi.org/10.2337/dc11-1724
   PubMed Web of Science ®Google Scholar
• Ueba T, Nomura S, Inami N, Nishikawa T, Kajiwara M, Iwata R, Yamashita K. Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men, 2010;17(4):342–349. doi: https://doi.org/10.5551/jat.2964.
   Google Scholar